Skip to main content
. 2014 Apr 21;12(1):12. doi: 10.1186/1897-4287-12-12

Figure 1.

Figure 1

Endometrial cancers in carriers of PMS2 c.989-1G > T with and without expression of PMS2. IHC analysis of two adenocarcinomas of the endometrium. Immunhistochemical reaction shows expression (left) or no expression (right) of PMS2. Magnification × 20. Lymphocytes in the tumour sample provide positive control. Both tumours displayed MSI.